Skip Navigation
  • The MHH
  • International office
  • Emergency numbers
  • Patients & Visitors
  • Facilities & Departments
    • Facilities & Departments
    • MHH Clinical departments
    • MHH-Institutes
    • Clinical departments and institutes sorted by center
    • Interdisciplinary centers
    • Central facilities
  • Research
    • Research
    • Research foci
      • Research foci
      • COVID-19
    • Core Research Units
      • Core Research Units
      • MeDIC
      • Hannover Unified Biobank (HUB)
      • Lasermikroskopie
      • Research Core Unit Electron Microscopy
    • Academic Career Development
    • Advisory Services
      • Advisory Services
      • DFG
    • Research Infrastructure
    • Dean of Research
    • Good Scientific Practice
      • Good Scientific Practice
      • Commission for Good Scientific Practice
      • Ombuds Office and Ombudsperson
    • Transparency in Research
    • Research Funding, Knowledge & Technology Transfer
      • Research Funding, Knowledge & Technology Transfer
      • Partners & Networks
      • For life scientists
      • For partners & investors
      • For startups and founders
  • Studying at MHH
    • Studying at MHH
    • All degree programs
    • Registrar's Office
      • Registrar's Office
      • Prospective students
      • Students
      • Dates & deadlines
      • Contact
  • Careers
    • Careers
    • MTR - Our diagnostics specialists with insight
Welcome to the MHH
Searched for *. Found 2106 results in 1 Millisekunden.

Filter by:

  • All content
  • Common content
  • Ambulances
  • News
  • «
  • …
  • 11
  • 12
  • 13
  • 14
  • 15
  • 16
  • 17
  • 18
  • 19
  • 20
  • …
  • »
News

MHH researcher wants to develop gene therapy against hearing and balance disorders

Relevance: 100%
 

17. November 2022 Protecting children and adults from hereditary deafness with the help of gene therapy is one of the goals of Professor Dr. Dr. Axel Schambach, head of the Institute for Experimental

News

Hannover Medical School scientists highly regarded

Relevance: 100%
 

16.11.2022 Three scientists from Hannover Medical School are among the most frequently cited researchers in the world: Professor Dr. Michael Manns, Professor Dr. Thomas Werfel and Professor Dr. Thomas

News

New gene taxis to combat liver disease

Relevance: 100%
 

26.10.2022 There are numerous severe, hardly treatable monogenetic diseases that are caused by a defect in a single gene - also in the liver. These include the blood coagulation disorders haemophilia

News

MHH: 4.6 million euros follow-up funding for sugar research

Relevance: 100%
 

10.11.2022 Sugar compounds from the glycan group play an important role in many biological processes in our body. By chemically combining with proteins and fats and thereby changing them, they regulat

News

Fatty liver is increasingly the cause of liver cell cancer

Relevance: 100%
 

19.10.2022 Hepatocellular carcinoma (HCC) is one of the most common cancers worldwide. In Germany, there are currently around 9,000 new HCC diagnoses per year, and almost 8,000 people affected do not

News

MHH: Gene correction as a possible therapy for iron storage disease

Relevance: 100%
 

21.10.2022 Hereditary primary haemochromatosis is one of the most common inborn errors of metabolism in Europe. In this disorder, also known as iron storage disease, the body is overloaded with iron.

News

Bundled competence for rare disease

Relevance: 100%
 

18.10.2022 Amyloidosis is a rare disease that can affect individual organs and body regions or the entire organism. It is caused by misfolded protein molecules that are deposited in the body. Since th

News

Botox influences the control of emotions in the brain

Relevance: 100%
 

22.09.2022 The bacterial toxin botulinum toxin (BTX) - colloquially known as Botox - is probably known to most people as a remedy for wrinkles. But botulinum toxin can do even more: if it is injected

News

Lung experts aim to combat COPD more effectively worldwide

Relevance: 100%
 

26.09.2022 Chronic obstructive pulmonary disease (COPD) is the most common chronic respiratory disease worldwide and the third leading cause of death. In Germany, about ten percent of the population i

News

At the MHH: Health insurance companies pay for early detection of rare disease

Relevance: 100%
 

23.09.2022 Li-Fraumeni syndrome (LFS) is a rare genetic disorder associated with a greatly increased risk of various types of cancer. The genetic defect can lead to multiple occurrences of malignant t

  • «
  • …
  • 11
  • 12
  • 13
  • 14
  • 15
  • 16
  • 17
  • 18
  • 19
  • 20
  • …
  • »
Imprint Intranet Contact Privacy Accessibility
The MHH Hospital is a maximum care hospital with a nationwide catchment area. The university teaches medicine, dentistry, biochemistry, biomedicine, midwifery and health sciences. The main research areas are Transplantation and Stem Cell Research / Regenerative Medicine, Infection and Immunology Research, Biomedical Engineering and Implant Research.

   

Information about

Blood donation service MHH-Alumni e.V.

Follow us on

Facebook Instagram YouTube Xing LinkedIn
© 2019 - 2025 Medizinische Hochschule Hannover
Nach oben scrollen